Literature DB >> 30989425

Implication of DNA repair genes in Lynch-like syndrome.

Rosa M Xicola1, Julia R Clark2, Timothy Carroll2, Jurgis Alvikas2, Priti Marwaha2, Maureen R Regan2, Francesc Lopez-Giraldez3, Jungmin Choi4, Rajyasree Emmadi5, Victoria Alagiozian-Angelova6, Sonia S Kupfer7, Nathan A Ellis8, Xavier Llor9.   

Abstract

Many colorectal cancers (CRCs) that exhibit microsatellite instability (MSI) are not explained by MLH1 promoter methylation or germline mutations in mismatch repair (MMR) genes, which cause Lynch syndrome (LS). Instead, these Lynch-like syndrome (LLS) patients have somatic mutations in MMR genes. However, many of these patients are young and have relatives with cancer, suggesting a hereditary entity. We performed germline sequence analysis in LLS patients and determined their tumor's mutational profiles using FFPE DNA. Six hundred and fifty-four consecutive CRC patients were screened for suspected LS using MSI and absence of MLH1 methylation. Suspected LS cases were exome sequenced to identify germline and somatic mutations. Single nucleotide variants were used to characterize mutational signatures. We identified 23 suspected LS cases. Germline sequence analysis of 16 available samples identified five cases with LS mutations and 11 cases without LS mutations, LLS. Most LLS tumors had a combination of somatic MMR gene mutation and loss of heterozygosity. LLS patients were relatively young and had excess first-degree relatives with cancer. Four of the 11 LLS patients had rare likely pathogenic variants in genes that maintain genome integrity. Moreover, tumors from this group had a distinct mutational signature compared to tumors from LLS patients lacking germline mutations in these genes. In summary, more than a third of the LLS patients studied had germline mutations in genes that maintain genome integrity and their tumors had a distinct mutational signature. The possibility of hereditary factors in LLS warrants further studies so counseling can be properly informed.

Entities:  

Keywords:  Colorectal cancer; DNA repair genes; Lynch syndrome; Lynch syndrome-like; Lynch-like syndrome

Mesh:

Substances:

Year:  2019        PMID: 30989425      PMCID: PMC6561810          DOI: 10.1007/s10689-019-00128-6

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  44 in total

1.  When should we suspect hereditary colorectal cancer syndrome?

Authors:  Xavier Llor
Journal:  Clin Gastroenterol Hepatol       Date:  2011-12-16       Impact factor: 11.382

2.  BLM heterozygosity and the risk of colorectal cancer.

Authors:  Stephen B Gruber; Nathan A Ellis; Karen K Scott; Ronit Almog; Prema Kolachana; Joseph D Bonner; Tomas Kirchhoff; Lynn P Tomsho; Khedoudja Nafa; Heather Pierce; Marcelo Low; Jaya Satagopan; Hedy Rennert; Helen Huang; Joel K Greenson; Joanna Groden; Beth Rapaport; Jinru Shia; Stephen Johnson; Peter K Gregersen; Curtis C Harris; Jeff Boyd; Gad Rennert; Kenneth Offit
Journal:  Science       Date:  2002-09-20       Impact factor: 47.728

3.  Loss of DNA polymerase zeta enhances spontaneous tumorigenesis.

Authors:  John P Wittschieben; Vaishali Patil; Veronika Glushets; Lisa J Robinson; Donna F Kusewitt; Richard D Wood
Journal:  Cancer Res       Date:  2010-03-09       Impact factor: 12.701

Review 4.  The NCI60 human tumour cell line anticancer drug screen.

Authors:  Robert H Shoemaker
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

5.  Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors.

Authors:  Rosa M Xicola; Xavier Llor; Elisenda Pons; Antoni Castells; Cristina Alenda; Virgínia Piñol; Montserrat Andreu; Sergi Castellví-Bel; Artemio Payá; Rodrigo Jover; Xavier Bessa; Anna Girós; José M Duque; David Nicolás-Pérez; Ana M Garcia; Joaquin Rigau; Miquel A Gassull
Journal:  J Natl Cancer Inst       Date:  2007-02-07       Impact factor: 13.506

6.  Biallelic MUTYH mutations can mimic Lynch syndrome.

Authors:  Monika Morak; Barbara Heidenreich; Gisela Keller; Heather Hampel; Andreas Laner; Albert de la Chapelle; Elke Holinski-Feder
Journal:  Eur J Hum Genet       Date:  2014-02-12       Impact factor: 4.246

7.  BRIT1 regulates p53 stability and functions as a tumor suppressor in breast cancer.

Authors:  Bo Zhang; Edward Wang; Hui Dai; Ruozhen Hu; Yulong Liang; Kaiyi Li; Guobin Wang; Guang Peng; Shiaw-Yih Lin
Journal:  Carcinogenesis       Date:  2013-06-01       Impact factor: 4.944

8.  Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer.

Authors:  Fadwa A Elsayed; C Marleen Kets; Dina Ruano; Brendy van den Akker; Arjen R Mensenkamp; Melanie Schrumpf; Maartje Nielsen; Juul T Wijnen; Carli M Tops; Marjolijn J Ligtenberg; Hans F A Vasen; Frederik J Hes; Hans Morreau; Tom van Wezel
Journal:  Eur J Hum Genet       Date:  2014-11-05       Impact factor: 4.246

9.  Evidence for Msh2 haploinsufficiency in mice revealed by MNU-induced sister-chromatid exchange analysis.

Authors:  S D Bouffler; N Hofland; R Cox; R Fodde
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

10.  Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer.

Authors:  Richarda M de Voer; Marc-Manuel Hahn; Arjen R Mensenkamp; Alexander Hoischen; Christian Gilissen; Arjen Henkes; Liesbeth Spruijt; Wendy A van Zelst-Stams; C Marleen Kets; Eugene T Verwiel; Iris D Nagtegaal; Hans K Schackert; Ad Geurts van Kessel; Nicoline Hoogerbrugge; Marjolijn J L Ligtenberg; Roland P Kuiper
Journal:  Sci Rep       Date:  2015-09-11       Impact factor: 4.379

View more
  12 in total

1.  Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors.

Authors:  Berbel L M Ykema; Emilie C H Breekveldt; Beatriz Carvalho; Tom van Wezel; Gerrit A Meijer; Martijn Kerst; Michael Schaapveld; Flora E van Leeuwen; Petur Snaebjornsson; Monique E van Leerdam
Journal:  Br J Cancer       Date:  2022-09-10       Impact factor: 9.075

2.  Mutational signature profiling classifies subtypes of clinically different mismatch-repair-deficient tumours with a differential immunogenic response potential.

Authors:  Mar Giner-Calabuig; Seila De Leon; Julian Wang; Tara D Fehlmann; Chinedu Ukaegbu; Joanna Gibson; Miren Alustiza-Fernandez; Maria-Dolores Pico; Cristina Alenda; Maite Herraiz; Marta Carrillo-Palau; Inmaculada Salces; Josep Reyes; Silvia P Ortega; Antònia Obrador-Hevia; Michael Cecchini; Sapna Syngal; Elena Stoffel; Nathan A Ellis; Joann Sweasy; Rodrigo Jover; Xavier Llor; Rosa M Xicola
Journal:  Br J Cancer       Date:  2022-02-23       Impact factor: 9.075

3.  Prevalence and Molecular Characterization of Defective DNA Mismatch Repair in Small-bowel Carcinoma in a Japanese Hospital-based Population.

Authors:  Tetsuya Ito; Hideyuki Ishida; Okihide Suzuki; Noriyasu Chika; Kunihiko Amano; Keiichiro Ishibashi; Nao Kamae; Yuhki Tada; Kiwamu Akagi; Hidetaka Eguchi; Yasushi Okazaki
Journal:  J Anus Rectum Colon       Date:  2020-10-29

Review 4.  Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors.

Authors:  Julie Leclerc; Catherine Vermaut; Marie-Pierre Buisine
Journal:  Cancers (Basel)       Date:  2021-01-26       Impact factor: 6.639

5.  MLH1 promoter hypermethylation predicts poorer prognosis in mismatch repair deficiency endometrial carcinomas.

Authors:  Enami Kaneko; Naoki Sato; Tae Sugawara; Aya Noto; Kazue Takahashi; Kenichi Makino; Yukihiro Terada
Journal:  J Gynecol Oncol       Date:  2021-08-04       Impact factor: 4.401

Review 6.  Lynch-like Syndrome: Potential Mechanisms and Management.

Authors:  Alejandro Martínez-Roca; Mar Giner-Calabuig; Oscar Murcia; Adela Castillejo; José Luis Soto; Anabel García-Heredia; Rodrigo Jover
Journal:  Cancers (Basel)       Date:  2022-02-22       Impact factor: 6.639

7.  Testing for Lynch Syndrome in Endometrial Carcinoma: From Universal to Age-Selective MLH1 Methylation Analysis.

Authors:  Annukka Pasanen; Mikko Loukovaara; Elina Kaikkonen; Alisa Olkinuora; Kirsi Pylvänäinen; Pia Alhopuro; Päivi Peltomäki; Jukka-Pekka Mecklin; Ralf Bützow
Journal:  Cancers (Basel)       Date:  2022-03-06       Impact factor: 6.639

8.  Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma.

Authors:  Annukka Pasanen; Mikko Loukovaara; Ralf Bützow
Journal:  Mod Pathol       Date:  2020-02-14       Impact factor: 7.842

9.  Array comparative genomic hybridization based identification of key genetic alterations at 2p21-p16.3 (MSH2, MSH6, EPCAM), 3p23-p14.2 (MLH1), 7p22.1 (PMS2) and 1p34.1-p33 (MUTYH) regions in hereditary non polyposis colorectal cancer (Lynch syndrome) in the Kingdom of Saudi Arabia.

Authors:  Mahmood Rasool; Peter Natesan Pushparaj; Zeenat Mirza; Muhammad Imran Naseer; Heba Abusamra; Maha Alquaiti; Manal Shaabad; Abdulrahman Mohamed Saeed Sibiany; Kalamegam Gauthaman; Mohammed Hussein Al-Qahtani; Sajjad Karim
Journal:  Saudi J Biol Sci       Date:  2019-06-15       Impact factor: 4.219

10.  Germline biallelic Mcm8 variants are associated with early-onset Lynch-like syndrome.

Authors:  Mariano Golubicki; Laia Bonjoch; José G Acuña-Ochoa; Marcos Díaz-Gay; Jenifer Muñoz; Miriam Cuatrecasas; Teresa Ocaña; Soledad Iseas; Guillermo Mendez; Daniel Cisterna; Stephanie A Schubert; Maartje Nielsen; Tom van Wezel; Yael Goldberg; Eli Pikarsky; Juan Robbio; Enrique Roca; Antoni Castells; Francesc Balaguer; Marina Antelo; Sergi Castellví-Bel
Journal:  JCI Insight       Date:  2020-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.